eScholarshipmetadata only
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer
32 biomedical and clinical sciences (for-2020), 3211 oncology and carcinogenesis (for-2020), clinical research (rcdc), digestive diseases (rcdc), colo-rectal cancer (rcdc), genetics (rcdc), precision medicine (rcdc), biotechnology (rcdc)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 814598
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.